These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 39187900)

  • 1. Growth dynamics of lung nodules: implications for classification in lung cancer screening.
    Ocaña-Tienda B; Eroles-Simó A; Pérez-Beteta J; Arana E; Pérez-García VM
    Cancer Imaging; 2024 Aug; 24(1):113. PubMed ID: 39187900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.
    Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M
    Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
    Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
    Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume.
    Tammemagi M; Ritchie AJ; Atkar-Khattra S; Dougherty B; Sanghera C; Mayo JR; Yuan R; Manos D; McWilliams AM; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Seely JM; Burrowes P; Bhatia R; Haider EA; Boylan C; Jacobs C; van Ginneken B; Tsao MS; Lam S;
    J Thorac Oncol; 2019 Feb; 14(2):203-211. PubMed ID: 30368011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines.
    van Riel SJ; Ciompi F; Jacobs C; Winkler Wille MM; Scholten ET; Naqibullah M; Lam S; Prokop M; Schaefer-Prokop C; van Ginneken B
    Eur Radiol; 2017 Oct; 27(10):4019-4029. PubMed ID: 28293773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
    Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
    Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant Nodules Detected on Lung Cancer Screening CT: Yield of Short-Term Follow-Up CT in Showing Nodule Growth.
    Byrne SC; Hammer MM
    AJR Am J Roentgenol; 2022 Nov; 219(5):735-741. PubMed ID: 35674352
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative CT analysis of lung parenchyma to improve malignancy risk estimation in incidental pulmonary nodules.
    Peters AA; Weinheimer O; von Stackelberg O; Kroschke J; Piskorski L; Debic M; Schlamp K; Welzel L; Pohl M; Christe A; Ebner L; Kauczor HU; Heußel CP; Wielpütz MO
    Eur Radiol; 2023 Jun; 33(6):3908-3917. PubMed ID: 36538071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals.
    Heuvelmans MA; Oudkerk M; de Bock GH; de Koning HJ; Xie X; van Ooijen PM; Greuter MJ; de Jong PA; Groen HJ; Vliegenthart R
    Eur Radiol; 2013 Jul; 23(7):1836-45. PubMed ID: 23508275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Patient With a Pulmonary Nodule: A Review.
    Mazzone PJ; Lam L
    JAMA; 2022 Jan; 327(3):264-273. PubMed ID: 35040882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
    Yip R; Henschke CI; Xu DM; Li K; Jirapatnakul A; Yankelevitz DF
    AJR Am J Roentgenol; 2017 May; 208(5):1011-1021. PubMed ID: 28245151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.
    Gierada DS; Pinsky P; Nath H; Chiles C; Duan F; Aberle DR
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25326638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size and Growth Assessment of Pulmonary Nodules: Consequences of the Rounding.
    Li K; Yip R; Avila R; Henschke CI; Yankelevitz DF
    J Thorac Oncol; 2017 Apr; 12(4):657-662. PubMed ID: 28007625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probability of cancer in pulmonary nodules detected on first screening CT.
    McWilliams A; Tammemagi MC; Mayo JR; Roberts H; Liu G; Soghrati K; Yasufuku K; Martel S; Laberge F; Gingras M; Atkar-Khattra S; Berg CD; Evans K; Finley R; Yee J; English J; Nasute P; Goffin J; Puksa S; Stewart L; Tsai S; Johnston MR; Manos D; Nicholas G; Goss GD; Seely JM; Amjadi K; Tremblay A; Burrowes P; MacEachern P; Bhatia R; Tsao MS; Lam S
    N Engl J Med; 2013 Sep; 369(10):910-9. PubMed ID: 24004118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of low-dose dual-input computed tomography perfusion in the differential diagnosis of pulmonary benign and malignant ground-glass nodules.
    Hu X; Gou J; Wang L; Lin W; Li W; Yang F
    Sci Rep; 2024 Jul; 14(1):17098. PubMed ID: 39048627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
    Hou S; Lin X; Wang S; Shen Y; Meng Z; Jia Q; Tan J
    Medicine (Baltimore); 2018 Aug; 97(31):e11640. PubMed ID: 30075545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules.
    Revel MP; Merlin A; Peyrard S; Triki R; Couchon S; Chatellier G; Frija G
    AJR Am J Roentgenol; 2006 Jul; 187(1):135-42. PubMed ID: 16794167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.